Metyrapone/Oxazepam

美替拉酮/奥沙西泮

Report date: 2024/11/24 20:00:04

Base Information

Drug NameMetyrapone/Oxazepam
Drug Alias Name奥沙西泮/美替拉酮Oxazepam/MetyraponeEMB-001CEMB-001
ClassificationSmall molecules
Mechanisms of ActionGamma-aminobutyric acid A receptor agonistsSteroid 11-beta-hydroxylase inhibitors
TargetsGamma-aminobutyric acid A receptorSteroid 11-beta-hydroxylase
Therapy Area/IndicationsSmoking CessationTobacco Use DisorderCocaine-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes MetyraponeOxazepam
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLouisiana State University
China Registration ClassN/A

Develop Information

Active CompaniesEmbera Neurotherapeutics Inc
Inactive CompaniesRose Research Center Llc
Active IndicationsCocaine-Related Disorders
Inactive IndicationsSmoking CessationTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A